Virtual Medicinal Product (VMP) - Mizolastine 10mg modified-release tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Mizolastine 10mg modified-release tablets Start Date 02-11-2002 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Modified-release tablet
Ontology Form/Route
tabletmodified-release.oral
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
R06AX25
BNF Start Date End Date
Current BNF 03040100 Start Date 04-04-2022 End Date
Previous BNF 03040100 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39108011000001100 21-10-2020
320831001 02-11-2002 20-10-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Mizolastine Based on Ingredient Substance 10 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 tablet